Testing effectiveness (Phase 2)Ended earlyNCT04985604
What this trial is testing
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
Who this might be right for
MelanomaSolid TumorCRAF Gene Amplification+20 more
Day One Biopharmaceuticals, Inc. 23